Beverly Bell

Cognitive and Academic Late Effects Among Children Previously Treated for Acute Lymphocytic Leukemia Receiving Chemotherapy as CNS Prophylaxis

Ronald T. Brown, Avi Madan‐Swain, Gary A. Walco et al. · Journal of Pediatric Psychology · 1998 · 148 citations · Full text

Medicine, Oncology, Pediatrics +17

Phase I Trial and Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Topotecan Using a Five-Day Course in Children with Refractory Solid Tumors

David G. Tubergen, Clinton F. Stewart, Charles B. Pratt et al. · Journal of Pediatric Hematology/Oncology · 1996 · 126 citations

Medicine, Oncology, Pharmacology +17

Prospective Analysis of <i>TEL</i> Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Jeffrey E. Rubnitz, David Wichlan, Meenakshi Devidas et al. · Journal of Clinical Oncology · 2008 · 84 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: a Pediatric Oncology Group Study.

Robert L. Saylors, Clinton F. Stewart, William C. Zamboni et al. · Journal of Clinical Oncology · 1998 · 78 citations

Medicine, Oncology, Pharmacotherapy +17

Neurocognitive and Neuroradiologic Central Nervous System Late Effects in Children Treated on Pediatric Oncology Group (POG) P9605 (Standard Risk) and P9201 (Lesser Risk) Acute Lymphoblastic Leukemia Protocols (ACCL0131)

Patricia K. Duffner, F. Daniel Armstrong, Lu Chen et al. · Journal of Pediatric Hematology/Oncology · 2013 · 75 citations

Medicine, Oncology, Pediatrics +17